<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37953801</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Role of Tau protein in long COVID and potential therapeutic targets.</ArticleTitle><Pagination><StartPage>1280600</StartPage><MedlinePgn>1280600</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1280600</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1280600</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Long COVID is an emerging public health burden and has been defined as a syndrome with common symptoms of fatigue, shortness of breath, cognitive dysfunction, and others impacting day-to-day life, fluctuating or relapsing over, occurring for at least two months in patients with a history of probable or confirmed SARS CoV-2 infection; usually three months from the onset of illness and cannot be explained by an alternate diagnosis. The actual prevalence of long-term COVID-19 is unknown, but it is believed that more than 17 million patients in Europe may have suffered from it during pandemic.</AbstractText><AbstractText Label="PATHOPHYSIOLOGY">Currently, there is limited understanding of the pathophysiology of this syndrome, and multiple hypotheses have been proposed. Our literature review has shown studies reporting tau deposits in tissue samples of the brain from autopsies of COVID-19 patients compared to the control group, and the in-vitro human brain organoid model has shown aberrant phosphorylation of tau protein in response to SARS-CoV-2 infection. Tauopathies, a group of neurodegenerative disorders with the salient features of tau deposits, can manifest different symptoms based on the anatomical region of brain involvement and have been shown to affect the peripheral nervous system as well and explained even in rat model studies. Long COVID has more than 203 symptoms, with predominant symptoms of fatigue, dyspnea, and cognitive dysfunction, which tauopathy-induced CNS and peripheral nervous system dysfunction can explain. There have been no studies up till now to reveal the pathophysiology of long COVID. Based on our literature review, aberrant tau phosphorylation is a promising hypothesis that can be explored in future studies. Therapeutic approaches for tauopathies have multidimensional aspects, including targeting post-translational modifications, tau aggregation, and tau clearance through the autophagy process with the help of lysosomes, which can be potential targets for developing therapeutic interventions for the long COVID. In addition, future studies can attempt to find the tau proteins in CSF and use those as biomarkers for the long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Marwaha.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marwaha</LastName><ForeName>Bharat</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Adena Health System, Chillicothe, OH, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="Y">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="N">Tauopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic fatigue/myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">clinical symptoms of long covid</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">small fiber neuropathy</Keyword><Keyword MajorTopicYN="N">tau protein</Keyword></KeywordList><CoiStatement>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>4</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37953801</ArticleId><ArticleId IdType="pmc">PMC10634420</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1280600</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akihiko A., Michiaki M., Naoko S., Kazuhiko K., Hideki K., Shun I., et al. . (2021). Small fibre neuropathy is associated with impaired vascular endothelial function in patients with type 2 diabetes. Journal=Frontiers Endocrinol. 12. doi:&#xa0;10.3389/fendo.2021.653277. ISSN=1664-2392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.653277</ArticleId><ArticleId IdType="pmc">PMC8079951</ArticleId><ArticleId IdType="pubmed">33935969</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht P. J., Hines S., Eisenberg E., Pud D., Finlay D. R., Connolly K. M., et al. . (2006). Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain 120 (3), 244&#x2013;266. doi: 10.1016/j.pain.2005.10.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2005.10.035</ArticleId><ArticleId IdType="pubmed">16427199</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht P. J., Hou Q., Argoff C. E., Storey J. R., Wymer J. P., Rice F. L. (2013). Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue. Pain Med. 14, 895&#x2013;915. doi: 10.1111/pme.12139</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pme.12139</ArticleId><ArticleId IdType="pubmed">23691965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando K., Kabova A., Stygelbout V., Leroy K., Heraud C., Fr&#xe9;d&#xe9;rick C., et al. . (2014). Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.J. Alzheimers Dis. 40 (Suppl.1), S135&#x2013;S145. doi:&#xa0;10.3233/jad-132237</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-132237</ArticleId><ArticleId IdType="pubmed">24614899</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T., Br&#xfc;ckner M. K., Mosch B., L&#xf6;sche A. (2010). Selective cell death of hyperploid neurons in Alzheimer's disease. Am. J. Pathol. 177 (1), 15&#x2013;20. doi: 10.2353/ajpath.2010.090955</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090955</ArticleId><ArticleId IdType="pmc">PMC2893646</ArticleId><ArticleId IdType="pubmed">20472889</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo-Rodriguez I., Buitrago-Garcia D., Simancas-Racines D., Zambrano-Achig P., Campo R.d., Ciapponi A., et al. . (2020). False-negative results of initial RT-PCR assays for COVID-19: a systematic Review. medRxiv. doi: 10.1371/journal.pone.0242958</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242958</ArticleId><ArticleId IdType="pmc">PMC7728293</ArticleId><ArticleId IdType="pubmed">33301459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton N. J., AL B., TA P., TK K., Lantero-Rodriguez J., WS B., et al. . (2022). Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease. EBioMedicine. 76, 103836. doi:&#xa0;10.1016/j.ebiom.2022.103836</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103836</ArticleId><ArticleId IdType="pmc">PMC8850760</ArticleId><ArticleId IdType="pubmed">35158308</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N., Le Guen M., Russel S., Touche P., Huang F., Vall&#xe9;e A. (2021). Clinical characterization of dysautonomia in long COVID-19 patients. Sci. Rep. 11 (1), 14042. doi:&#xa0;10.1038/s41598-021-93546-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., EB C., Rangel &#xc9;B. (2021). COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect. Dis. 40 (5), 905&#x2013;919. doi:&#xa0;10.1007/s10096-020-04138-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G., Korkmaz C., Zamani A., Ozkagnici A., Zengin N., Ponirakis G., et al. . (2021). Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. Br. J. Ophthalmol 106 (12), 1635&#x2013;1641. doi:&#xa0;10.1136/bjophthalmol-2021-319450</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2021-319450</ArticleId><ArticleId IdType="pmc">PMC8359871</ArticleId><ArticleId IdType="pubmed">34312122</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt R., Leger J., Lee G. (1995). Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131, 1327&#x2013;1340. doi: 10.1083/jcb.131.5.1327</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.131.5.1327</ArticleId><ArticleId IdType="pmc">PMC2120645</ArticleId><ArticleId IdType="pubmed">8522593</ArticleId></ArticleIdList></Reference><Reference><Citation>Brier M. R., Gordon B., Friedrichsen K., McCarthy J., Stern A., Christensen J., et al. . (2016). Tau and Abeta imaging, CSF measures, and cognition in Alzheimer&#x2019;s disease. Sci Transl. Med. 8 (338), 338ra366. doi:&#xa0;10.1126/scitranslmed.aaf2362</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf2362</ArticleId><ArticleId IdType="pmc">PMC5267531</ArticleId><ArticleId IdType="pubmed">27169802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T. K., Adjei S., Gray S., et al. . (2022). Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United states, march 2020&#x2013;november 2021. MMWR Morb Mortal Wkly Rep 71, 713&#x2013;717. doi:&#xa0;10.15585/mmwr.mm7121e1external.icon</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1external.icon</ArticleId></ArticleIdList></Reference><Reference><Citation>Calcutt N. A., Jolivalt C. G., Fernyhough P. (2008). Growth factors as therapeutics for diabetic neuropathyCurr. Drug Targets 9, 47&#x2013;59. doi: 10.2174/138945008783431727</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945008783431727</ArticleId><ArticleId IdType="pubmed">18220712</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC  (2020) Healthcare Workers [Internet] Centers for disease control and prevention. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Chen M., Du Z. Y., Zheng X., Li D. L., Zhou R. P., Zhang K. (2018). Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease. Neural Regen. Res. 13, 742&#x2013;752. doi:&#xa0;10.4103/1673-5374.230303</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.230303</ArticleId><ArticleId IdType="pmc">PMC5950688</ArticleId><ArticleId IdType="pubmed">29722330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimento A., De Amicis F., Sirianni R., Sinicropi M. S., Puoci F., Casaburi I., et al. . (2019). Progress to improve oral bioavailability and beneficial effects of resveratrol.Int. J. Mol. Sci. 20, 1381. doi:&#xa0;10.3390/ijms20061381</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061381</ArticleId><ArticleId IdType="pmc">PMC6471659</ArticleId><ArticleId IdType="pubmed">30893846</ArticleId></ArticleIdList></Reference><Reference><Citation>Costela-Ruiz V. J., Illescas-Montes R., Puerta-Puerta J. M., Ruiz C., Melguizo-Rodr&#xed;guez L. (2020). SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth factor Rev. 54, 62&#x2013;75. doi:&#xa0;10.1016/j.cytogfr.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7265853</ArticleId><ArticleId IdType="pubmed">32513566</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J., Li F., Shi Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181&#x2013;192. doi: 10.1038/s41579-018-0118-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0118-9</ArticleId><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies D. A., Adlimoghaddam A., Albensi B. C. (2021). The effect of COVID-19 on NF-&#x3ba;B and neurological manifestations of disease. Mol. Neurobiol. 58 (8), 4178&#x2013;4187. doi:&#xa0;10.1007/s12035-021-02438-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02438-2</ArticleId><ArticleId IdType="pmc">PMC8169418</ArticleId><ArticleId IdType="pubmed">34075562</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re'em Y., et al. . (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine 38, 101019. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>de Calignon A., Polydoro M., Su&#xe1;rez-Calvet M., William C., Adamowicz D. H., Kopeikina K. J., et al. . (2012). Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73 (4), 685&#x2013;697. doi: 10.1016/j.neuron.2011.11.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.11.033</ArticleId><ArticleId IdType="pmc">PMC3292759</ArticleId><ArticleId IdType="pubmed">22365544</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos S. L., Miller R. L., Schoch K. M., Holmes B. B., Kebodeaux C. S., Wegener A. J., et al. . (2017). Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci. Transl. Med. 9, eaag0481. doi:&#xa0;10.1126/scitranslmed.aag0481</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aag0481</ArticleId><ArticleId IdType="pmc">PMC5792300</ArticleId><ArticleId IdType="pubmed">28123067</ArticleId></ArticleIdList></Reference><Reference><Citation>Drubin D. G., Feinstein S. C., Shooter E. M., Kirschner M. W. (1985). Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J. Cell Biol. 101, 1799&#x2013;1807. doi: 10.1083/jcb.101.5.1799</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.101.5.1799</ArticleId><ArticleId IdType="pmc">PMC2113947</ArticleId><ArticleId IdType="pubmed">2997236</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchesne M., Richard L., JM V., Magy L. (2018). Assessing sudomotor impairment in patients with peripheral neuropathy: comparison between electrochemical skin conductance and skin biopsy. Clin. Neurophysiol. 129 (7), 1341&#x2013;1348. doi: 10.1016/j.clinph.2018.04.608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.04.608</ArticleId><ArticleId IdType="pubmed">29729587</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta D., Liu J., Xiong H. (2022). NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes. Int. J. Physiol. Pathophysiol. Pharmacol. 14 (3), 138&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9301183</ArticleId><ArticleId IdType="pubmed">35891930</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabry V., Gerdelat A., Acket B., Cintas P., Rousseau V., Uro-Coste E., et al. . (2020). Which method for diagnosing small fiber neuropathy? Front. Neurol. 11:342. doi:&#xa0;10.3389/fneur.2020.00342</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00342</ArticleId><ArticleId IdType="pmc">PMC7214721</ArticleId><ArticleId IdType="pubmed">32431663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I., Gomez-Isla T., Puig B., Freixes M., Rib&#xe9; E., Dalf&#xf3; E., et al. . (2005). Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer&#x2019;s disease and tauopathies Curr. Alzheimer Res. 2, 3&#x2013;18. doi: 10.2174/1567205052772713</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205052772713</ArticleId><ArticleId IdType="pubmed">15977985</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B., Jacks R. L., Diamond M. I. (2009). Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284 (19), 12845&#x2013;12852. doi: 10.1074/jbc.M808759200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M808759200</ArticleId><ArticleId IdType="pmc">PMC2676015</ArticleId><ArticleId IdType="pubmed">19282288</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B., Hemberg M., Lewis J., Feany M. B. (2014). Tau promotes neurodegeneration through global chromatin relaxation. Nat. Neurosci. 17 (3), 357&#x2013;366. doi: 10.1038/nn.3639</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3639</ArticleId><ArticleId IdType="pmc">PMC4012297</ArticleId><ArticleId IdType="pubmed">24464041</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B., Bardai F. H., Feany M. B. (2016). Lamin dysfunction mediates neurodegeneration in tauopathies. Curr. Biol. 26 (1), 129&#x2013;136. doi: 10.1016/j.cub.2015.11.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.11.039</ArticleId><ArticleId IdType="pmc">PMC4713335</ArticleId><ArticleId IdType="pubmed">26725200</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulga T. A., Elson-Schwab I., Khurana V., Steinhilb M. L., Spires T. L., Hyman B. T., et al. . (2007). Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo . Nat. Cell Biol. 9 (2), 139&#x2013;148. doi: 10.1038/ncb1528</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1528</ArticleId><ArticleId IdType="pubmed">17187063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemzadeh S., Riazi G. H. (2020). Inhibition of Tau amyloid fibril formation by folic acid: In-vitro and theoretical studies.Int. J. Biol. Macromol. 154, 1505&#x2013;1516. doi:&#xa0;10.1016/j.ijbiomac.2019.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.11.032</ArticleId><ArticleId IdType="pubmed">31751728</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E. J., Mustapic M., Kapogiannis D., Eitan E., Lobach. I. V., Goetzl L., et al. . (2016). Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease. FASEB J. 30 (11), 3853&#x2013;3859. doi: 10.1096/fj.201600756R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600756R</ArticleId><ArticleId IdType="pmc">PMC5067254</ArticleId><ArticleId IdType="pubmed">27511944</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudowska-Sawczuk M., Mroczko B. (2022). The role of nuclear factor kappa B (NF-&#x3ba;B) in development and treatment of COVID-19: review. Int. J. Mol. Sci. 23 (9), 5283. doi:&#xa0;10.3390/ijms23095283</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23095283</ArticleId><ArticleId IdType="pmc">PMC9101079</ArticleId><ArticleId IdType="pubmed">35563673</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Noble W., Hanger D. P. (2017). Roles of tau protein in health and disease. Acta Neuropathol. 133, 665&#x2013;704. doi:&#xa0;10.1007/s00401-017-1707-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1707-9</ArticleId><ArticleId IdType="pmc">PMC5390006</ArticleId><ArticleId IdType="pubmed">28386764</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanger D. P., Goniotaki D., Noble W. (2019). Synaptic localisation of tau. Adv. Exp. Med. Biol. 1184, 105&#x2013;112. doi: 10.1007/978-981-32-9358-8_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-32-9358-8_9</ArticleId><ArticleId IdType="pubmed">32096032</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L. (2006). Association between CSF biomarkers and incipient Alzheimer&#x2019;s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 5, 228&#x2013;234. doi: 10.1016/S1474-4422(06)70355-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70355-6</ArticleId><ArticleId IdType="pubmed">16488378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., M&#xe9;ar L., Edvinsson &#xc5;., Micke P., Uhl&#xe9;n M., Lindskog C. (2020). The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 16, e9610. doi:&#xa0;10.15252/msb.20209610</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., et al. . (2020). SARS-coV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z. L. (2021). Characteristics of SARS-coV-2 and COVID-19. Nat. Rev. Microbiol. 19 (3), 141&#x2013;154. doi:&#xa0;10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua Q., He R. Q, Haque N, Qu M. H., del Carmen Alonso A., Grundke-Iqbal I., et al. . (2003). Microtubule associated protein tau binds to double-stranded but not single-stranded DNA. Cell Mol. Life Sci. 60 (2), 413&#x2013;421. doi: 10.1007/s000180300034</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000180300034</ArticleId><ArticleId IdType="pmc">PMC11146073</ArticleId><ArticleId IdType="pubmed">12678504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C., Venegas C., Zhang S., Scheiblich H., Schmidt S. V., Vieira-Saecker A., et al. . (2019). NLRP3 inflammasome activation drives tau pathology. Nature 575 (7784), 669&#x2013;673. doi:&#xa0;10.1038/s41586-019-1769-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1769-z</ArticleId><ArticleId IdType="pmc">PMC7324015</ArticleId><ArticleId IdType="pubmed">31748742</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen P. H., Hager H., Nielsen M. S., H&#xf8;jrup P., Gliemann J., Jakes R. (1999). Alpha-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274, 25481&#x2013;25489. doi: 10.1074/jbc.274.36.25481</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.36.25481</ArticleId><ArticleId IdType="pubmed">10464279</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhang K. A., Park J. S., Kim H. S., Chong Y. H. (2017). Resveratrol ameliorates tau hyperphosphorylation at ser396 site and oxidative damage in rat hippocampal slices exposed to vanadate: implication of ERK1/2 and GSK-3&#x3b2; signaling cascades. J. Agric. Food Chem. 65, 9626&#x2013;9634. doi:&#xa0;10.1021/acs.jafc.7b03252</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.7b03252</ArticleId><ArticleId IdType="pubmed">29022339</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson K. A., Schultz A., Betensky R. A., Becker J. A., Sepulcre J., Rentz D., et al. . (2016). Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol. 79 (1), 110&#x2013;119. doi: 10.1002/ana.24546</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24546</ArticleId><ArticleId IdType="pmc">PMC4738026</ArticleId><ArticleId IdType="pubmed">26505746</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson S. A., Shouman K., Shelly S., Sandroni P., SE B., Dyck P. J. B., et al. . (2021). Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability. Neurology. 97 (22), e2236&#x2013;e2247. doi:&#xa0;10.1212/WNL.0000000000012894</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012894</ArticleId><ArticleId IdType="pmc">PMC8641968</ArticleId><ArticleId IdType="pubmed">34706972</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R. K. F., Faria-Urbina M., Felsenstein D., Oaklander A. L., et al. . (2021). Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 160 (2), 642&#x2013;651. doi:&#xa0;10.1016/j.chest.2021.01.082</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B. A., Pryor J. L., Giloteaux L. (2014). Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO(2)peak indicates functional impairment. JTransl Med. 12, 104. doi: 10.1186/1479-5876-12-104</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-104</ArticleId><ArticleId IdType="pmc">PMC4004422</ArticleId><ArticleId IdType="pubmed">24755065</ArticleId></ArticleIdList></Reference><Reference><Citation>King A. M. Q., Adams M. J., Carstens E. B., Lefkowitz E. J. (2012). &#x201c;Classification and nomenclature of viruses,&#x201d; in Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses (San Diego: Elsevier; ), 1326&#x2013;1327.</Citation></Reference><Reference><Citation>Kontsekova E., Zilka N., Kovacech B., Novak P., Novak M. (2014). First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model. Alzheimers. Res. Ther. 6, 44. doi:&#xa0;10.1186/alzrt278</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt278</ArticleId><ArticleId IdType="pmc">PMC4255368</ArticleId><ArticleId IdType="pubmed">25478017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucirka L. M., Lauer S. A., Laeyendecker O., Boon D., Lessler J. (2020). Variation in false-negative rate of reverse transcriptase polymerase chain reaction&#x2013;based SARS-CoV-2 tests by time since exposure. Ann. Intern. Med. doi: 10.7326/M20-1495</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-1495</ArticleId><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M. J., Lee J. H., Rubinsztein D. C. (2013). Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system. Prog. Neurobiol. 105, 49&#x2013;59. doi:&#xa0;10.1016/j.pneurobio.2013.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2013.03.001</ArticleId><ArticleId IdType="pubmed">23528736</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Jiang M., Xiao Y., Zhang X., Cui S., Huang G. (2015). Folic acid inhibits tau phosphorylation through regulation of PP2A methylation in SH-SY5Y cells. J. Nutr. Health Aging 19, 123&#x2013;129. doi:&#xa0;10.1007/s12603-014-0514-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-014-0514-4</ArticleId><ArticleId IdType="pubmed">25651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Feng J., Zhang Q., Guo D., Zhang L., Suo T., et al. . (2020). Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets. Emerg. Microbes Infect. 9, 1175&#x2013;1179. doi: 10.1080/22221751.2020.1772679</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1772679</ArticleId><ArticleId IdType="pmc">PMC7448863</ArticleId><ArticleId IdType="pubmed">32448084</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Grundke-Iqbal I., Iqbal K., Gong C.-X. (2005). Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942&#x2013;1950. doi: 10.1111/j.1460-9568.2005.04391.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2005.04391.x</ArticleId><ArticleId IdType="pubmed">16262633</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C. W. A., Lee G., Jay D. G. (1999). Tau is required for neurite outgrowth and growth cone motility of chick sensory neurons. Cell Motil. Cytoskeleton 43, 232&#x2013;242. doi: 10.1002/(SICI)1097-0169(1999)43:3&lt;232::AID-CM6&gt;3.0.CO;2-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0169(1999)43:3&lt;232::AID-CM6&gt;3.0.CO;2-7</ArticleId><ArticleId IdType="pubmed">10401579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W. J., Pogue A., Hill J. M. (2022). SARS-coV-2 infectivity and neurological targets in the brain. Cell Mol. Neurobiol. 42, 217&#x2013;224. doi:&#xa0;10.1007/s10571-020-00947-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D. M., Brunjes D. L., Lala A., Trivieri M. G., Contreras J. P., Natelson B. H. (2021). Use of cardiopulmonary stress testing for patients with unexplained dyspnea post&#x2013;coronavirus disease. JACC Heart Fail 9 (12), 927&#x2013;937. doi: 10.1016/j.jchf.2021.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangan M. S. J., Olhava E. J., Roush W. R., Seidel H. M., Glick G. D., Latz E. (2021). Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discovery 17 (9), 688. doi: 10.1038/nrd.2018.149</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.149</ArticleId><ArticleId IdType="pubmed">30116046</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez A., Guernsey L. S., Frizzi K. E., Cundiff M., Constantino I., Muttalib N., et al. . (2021). Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy. Neurobiol. Dis. 151, 105273. ISSN 0969-9961. doi: 10.1016/j.nbd.2021.105273</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105273</ArticleId><ArticleId IdType="pmc">PMC7925437</ArticleId><ArticleId IdType="pubmed">33482356</ArticleId></ArticleIdList></Reference><Reference><Citation>Motolani A., Martin M., Sun M., Lu T. (2021). Reference Module in Biomed Science. (Amsterdam, The Netherlands: Elsevier; ). NF-&#x3ba;B and Cancer Therapy Drugs.</Citation></Reference><Reference><Citation>Oaklander A. L., AJ M., Kelley M., LS T., Smith B., MC D., et al. . (2022). Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol. NeuroimmunolNeuroinflamm. 9 (3), e1146. doi:&#xa0;10.1212/NXI.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A. L., Fields H. L. (2009). Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann. Neurol. 65 (6), 629&#x2013;638. doi:&#xa0;10.1002/ana.21692</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21692</ArticleId><ArticleId IdType="pubmed">19557864</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldham W. M., Lewis G. D., Opotowsky A. R., Waxman A. B., Systrom D. M. (2016). Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testing. Pulm Circ. 6, 55&#x2013;62. doi: 10.1086/685054</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/685054</ArticleId><ArticleId IdType="pmc">PMC4860548</ArticleId><ArticleId IdType="pubmed">27162614</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B., Lautner R., Andreasson U., &#xd6;hrfelt A., Portelius E., Bjerke M., et al. . (2016). CSF and blood biomarkers for the diagnosis of Alzheimer&#x2019;s disease: a systematic review and meta-analysis. Lancet Neurol. 15, 673&#x2013;684. doi: 10.1016/S1474-4422(16)00070-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)00070-3</ArticleId><ArticleId IdType="pubmed">27068280</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr M. E., Sullivan A. C., Frost B. (2017). A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol. Sci. 38 (7), 637&#x2013;648. doi:&#xa0;10.1016/j.tips.2017.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2017.03.011</ArticleId><ArticleId IdType="pmc">PMC5476494</ArticleId><ArticleId IdType="pubmed">28455089</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M. J., Bakkers M., Merkies I. S., Hoeijmakers J. G., van Raak E. P., Faber C. G. (2013). Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology. 81 (15), 1356&#x2013;1360. doi:&#xa0;10.1212/WNL.0b013e3182a8236e</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a8236e</ArticleId><ArticleId IdType="pubmed">23997150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., M&#xfc;ller L., Ostermann P. N., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., et al. . (2020). SARS-CoV-2 targets neurons of 3D human brain organoid. EMBO J. 39 (20), e106230. doi: 10.15252/embj.2020106230</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane J. S., Bhaumik P., Panda D. (2017). Curcumin inhibits tau aggregation and disintegrates preformed tau filamentsin vitro . J. Alzheimers. Dis. 60, 999&#x2013;1014. doi:&#xa0;10.3233/jad-170351</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-170351</ArticleId><ArticleId IdType="pubmed">28984591</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S., Sittenfeld L., Dridi H., Liu Y., Liu X., Marks A. R. (2022). Alzheimer's-like signaling in brains of COVID-19 patients. Alzheimers Dement 18 (5), 955&#x2013;965. doi: 10.1002/alz.12558</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues T. S., de S&#xe1; K. S. G., Ishimoto A. Y., Becerra A., Oliveira S., Almeida L., et al. . (2021). Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 218 (3), e20201707. doi:&#xa0;10.1084/jem.20201707</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltin B., Blomqvist G., Mitchell J. H., Johnson J. R. L., Wildenthal K., Chapman C. B. (1968). Response to exercise after bed rest and after training. Circulation 38 (5 Suppl), VII1&#x2013;VII78.</Citation><ArticleIdList><ArticleId IdType="pubmed">5696236</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandusky-Beltran L. A., Sigurdsson E. M. (2020). Tau immunotherapies: lessons learned, current status and future considerations. Neuropharmacology 175, 108104. doi:&#xa0;10.1016/j.neuropharm.2020.108104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2020.108104</ArticleId><ArticleId IdType="pmc">PMC7492435</ArticleId><ArticleId IdType="pubmed">32360477</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuller T. B., Hermann K., Baron R. (2000). Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy. J. Neurol. 247 (4), 267&#x2013;272. doi: 10.1007/s004150050582</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050582</ArticleId><ArticleId IdType="pubmed">10836618</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweiger S., Matthes F., Posey K., Kickstein E., Weber S., Hettich M. M., et al. . (2017). Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex. Sci. Rep. 7, 13753. doi: 10.1038/s41598-017-12974-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12974-4</ArticleId><ArticleId IdType="pmc">PMC5653760</ArticleId><ArticleId IdType="pubmed">29062069</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw L. M., Vanderstichele H., Knapik-Czajka M., Clark C. M., Aisen P. S., Petersen R. C., et al. . (2009). Cerebrospinal fluid biomarker signature in Alzheimer&#x2019;s disease neuroimaging initiative subjects. Ann. Neurol. 65, 403&#x2013;413. doi: 10.1002/ana.21610</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21610</ArticleId><ArticleId IdType="pmc">PMC2696350</ArticleId><ArticleId IdType="pubmed">19296504</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeda Y., Takashima A. (2020). New insights into drug discovery targeting tau protein. Front. Mol. Neurosci. 13. doi:&#xa0;10.3389/fnmol.2020.590896. ISSN=1662-5099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.590896</ArticleId><ArticleId IdType="pmc">PMC7744460</ArticleId><ArticleId IdType="pubmed">33343298</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland M. K., Welsh R. C., Petersen S. R., Tyberg J. V., Anderson W. D., Jones R. L., et al. . (2006). Does fitness level modulate the cardiovascular hemodynamic response to exercise? JAppl Physiol. (1985) 100 (6), 1895&#x2013;1901. doi: 10.1152/japplphysiol.01485.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.01485.2005</ArticleId><ArticleId IdType="pubmed">16497838</ArticleId></ArticleIdList></Reference><Reference><Citation>Streeten D. H., Anderson G. H. Jr., Richardson R., Thomas F. D. (1988). Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling. J. Lab. Clin. Med. 111 (3), 326&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">3343547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C. H., Murray B., Varsavsky T., Graham M. S., Penfold R. S., Bowyer R. C., et al. . (2021). Attributes and predictors of long COVID. Nat. Med. 27 (4), 626&#x2013;631. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X. Y., Dong Q. X., Zhu J., Sun X., Zhang L. F., Qiu M., et al. . (2019). Resveratrol rescues tau-induced cognitive deficits and neuropathology in a mouse model of tauopathy.Curr. Alzheimer Res. 16, 710&#x2013;722. doi:&#xa0;10.2174/1567205016666190801153751</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205016666190801153751</ArticleId><ArticleId IdType="pubmed">31368873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun E., Motolani A., Campos L., Lu T. (2022). The pivotal role of NF-kB in the pathogenesis and therapeutics of alzheimer's disease. Int. J. Mol. Sci. 23 (16), 8972. doi:&#xa0;10.3390/ijms23168972</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23168972</ArticleId><ArticleId IdType="pmc">PMC9408758</ArticleId><ArticleId IdType="pubmed">36012242</ArticleId></ArticleIdList></Reference><Reference><Citation>Takei Y., Teng J., Harada A., Hirokawa N. (2000). Defects axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J. Cell Biol. 150, 989&#x2013;1000. doi: 10.1083/jcb.150.5.989</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.150.5.989</ArticleId><ArticleId IdType="pmc">PMC2175245</ArticleId><ArticleId IdType="pubmed">10973990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M. Z., Poh C. M., R&#xe9;nia L., MacAry P. A., Ng L. F. P. (2020).The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20 (6), 363&#x2013;374. doi: 10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K. T., Miller E. H., Glendinning M. D., Al-Dalahmah O., Banu M. A., Boehme A. K., et al. . (2021). COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain 144 (9), 2696&#x2013;2708. doi: 10.1093/brain/awab148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunis C., Crespo-Biel N., Gafner V., Pihlgren M., L&#xf3;pez-Deber M. P., Reis P., et al. . (2013). Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy. PloS One 8, e72301. doi:&#xa0;10.1371/journal.pone.0072301</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0072301</ArticleId><ArticleId IdType="pmc">PMC3747157</ArticleId><ArticleId IdType="pubmed">23977276</ArticleId></ArticleIdList></Reference><Reference><Citation>Troquier L., Caillierez R., Burnouf S., Fernandez-Gomez F. J., Grosjean M. E., Zommer N., et al. . (2012). Targeting phospho-Ser422 by active tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.Curr. Alzheimer Res. 9, 397&#x2013;405. doi:&#xa0;10.2174/156720512800492503</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720512800492503</ArticleId><ArticleId IdType="pmc">PMC3637173</ArticleId><ArticleId IdType="pubmed">22272619</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardhana S. A., Wolchok J. D. (2020). The many faces of the anti-COVID immune response. J. Exp. Med. 217, e20200678. doi: 10.1084/jem.20200678</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200678</ArticleId><ArticleId IdType="pmc">PMC7191310</ArticleId><ArticleId IdType="pubmed">32353870</ArticleId></ArticleIdList></Reference><Reference><Citation>Vareed S. K., Kakarala M., Ruffin M. T., Crowell J. A., Normolle D. P., Djuric Z., et al. . (2008). Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects.Cancer Epidemiol. Biomarkers Prev. 17, 1411&#x2013;1417. doi:&#xa0;10.1158/1055-9965.Epi-07-2693</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.Epi-07-2693</ArticleId><ArticleId IdType="pmc">PMC4138955</ArticleId><ArticleId IdType="pubmed">18559556</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Bharti, Kumar R., Pavlov P. F., Winblad B. (2021). Small molecule therapeutics for tauopathy in Alzheimer&#x2019;s disease: Walking on the path of most resistance. Eur. J. Medicinal Chem. 209, 112915. doi:&#xa0;10.1016/j.ejmech.2020.112915. ISSN 0223-5234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112915</ArticleId><ArticleId IdType="pubmed">33139110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Fan L., Khawaja R. R., Liu B., Zhan L., Kodama L., et al. . (2022). Microglial NF-&#x3ba;B drives tau spreading and toxicity in a mouse model of tauopathy. Nat. Commun. 13 (1), 1969. doi:&#xa0;10.1038/s41467-022-29552-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29552-6</ArticleId><ArticleId IdType="pmc">PMC9005658</ArticleId><ArticleId IdType="pubmed">35413950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y., Qu M. H., Wang X. S., Chen L., Wang D. L., Liu Y., et al. . (2008). Binding to the minor groove of the double-strand, tau protein prevents DNA from damage by peroxidation. PloS One 3 (7), e2600. doi: 10.1371/journal.pone.0002600</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002600</ArticleId><ArticleId IdType="pmc">PMC2432501</ArticleId><ArticleId IdType="pubmed">18596978</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarten M. D., Lockwood A. H., Hwo S. Y., Kirschner M. W. (1975. a). A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U S A. 72 (5), 1858&#x2013;1862. doi:&#xa0;10.1073/pnas.72.5.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.72.5.1858</ArticleId><ArticleId IdType="pmc">PMC432646</ArticleId><ArticleId IdType="pubmed">1057175</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarten M. D., Lockwood A. H., Hwo S. Y., Kirschner M. W. (1975. b). A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 72, 1858&#x2013;1862. doi: 10.1073/pnas.72.5.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.72.5.1858</ArticleId><ArticleId IdType="pmc">PMC432646</ArticleId><ArticleId IdType="pubmed">1057175</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe M. S. (2016). Developing Therapeutics for Alzheimer's Disease: Progress and Challenges (Cambridge, MA: Academic Press; ).</Citation></Reference><Reference><Citation>Xia E. Q., Deng G. F., Guo Y. J., Li H. B. (2010). Biological activities of polyphenols from grapes. Int. J. Mol. Sci. 11, 622&#x2013;646. doi:&#xa0;10.3390/ijms11020622</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms11020622</ArticleId><ArticleId IdType="pmc">PMC2852857</ArticleId><ArticleId IdType="pubmed">20386657</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nat. Med 28 (3), 583&#x2013;590. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A., Imahori K. (1996). Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase. 5, a component of TPK II. Acta Neuropathol. 92, 232&#x2013;241. doi:&#xa0;10.1007/s004010050513</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050513</ArticleId><ArticleId IdType="pubmed">8870824</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Kayama T., Noguchi-Shinohara M., Hamaguchi T., Yamada M., Abe K., et al. . (2021). Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway. NPJ Sci. Food. 5 (1), 1. doi:&#xa0;10.1038/s41538-021-00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41538-021-00084-5</ArticleId><ArticleId IdType="pmc">PMC7846760</ArticleId><ArticleId IdType="pubmed">33514742</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>